In a longitudinal follow-up study the effect of pharmaceutical supplementation of nutrients (folate, vitamin B12, B6, B1, C, iron and proteins) was established in 25 psychogeriatric patients (subject group). A reference group of 30 apparently healthy elderly subjects was used for comparison and statistical evaluation. At the time of hospitalization percentages concerning the incidence of decreased serum concentrations reflecting an inappropriate nutrient state in the subject group amounted to 28% for vitamin B12, 20% for folate, 36% for iron, 12% for transferrin and 56% for albumin concentrations. Increased plasma concentrations of homocysteine combined with decreased folate concentrations were found in 16% of the psychogeriatric patients. If compared with the initial results at admission, after three weeks of nutrient supplementation the vitamin B12 and folate serum concentrations were increased. Results for serum iron concentrations remained below the reference range interval in 5 of the 25 subjects reflecting iron deficiency. Initially decreased serum transferrin concentrations did not return to the reference range. Serum albumin levels still further decreased after admission to the hospital, resulting after three weeks in albumin concentrations below the reference range for 68% of the subjects. It is concluded that supplementation of folate and vitamin B12 lowered homocysteine plasma concentrations successfully. Supplementation of protein nutrients is not appropriate in order to restore disturbances of protein metabolism. Persisting low concentrations of proteins in serum are indicative of irreversible decreased synthesis.
Download full-text PDF |
Source |
---|
Exp Ther Med
February 2025
Department of Hematology, Etlik City Hospital, Ankara 06170, Turkey.
Whilst severe liver dysfunction is rarely encountered at the time of diagnosis for patients with acute myeloid leukemia (AML), mild elevations aminotransferase (<5 times the upper limit of normal) may be more frequently seen. Liver dysfunction at the time of diagnosis of AML is a parameter that requires investigation and can assist the clinicians in predicting prognosis. The aim of the present study was to investigate liver dysfunction at the time of diagnosis using the assoicated parameters in patients with AML.
View Article and Find Full Text PDFCureus
December 2024
Division of Internal Medicine, Unidade Local de Saúde de Braga, Braga, PRT.
Autoimmune polyglandular syndrome type 3 (APS-3) is an uncommon condition marked by autoimmune thyroid disease (ATD) linked with other autoimmune issues, excluding Addison's disease. We report a case of a 41-year-old man who was hospitalized due to exhaustion and macrocytic anemia, later diagnosed with APS-3, which included Hashimoto's thyroiditis, pernicious anemia resulting from autoimmune gastritis, and pre-existing vitiligo. Diagnostic results indicated positive intrinsic factor antibodies, a gastric biopsy compatible with gastritis, elevated thyroid peroxidase antibodies, and significant findings from a thyroid ultrasound.
View Article and Find Full Text PDFNeurol Res Pract
January 2025
Department of Vascular Neurology, University Hospital Bonn, Bonn, Germany.
Background: Nitrous oxide (N₂O), commonly known as laughing gas, is widely recognized for its anesthetic and analgesic effects, and is frequently used in medical contexts. However, its misuse can lead to significant neurological complications, which are often under-recognized in clinical practice. Recent data on such cases in Germany are rare.
View Article and Find Full Text PDFPediatr Res
January 2025
Department of Neurology, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, China.
Background: CblC type methylmalonic aciduria (cblC disease) is the most common inborn error of vitamin B12 metabolism and due to mutations in the MMACHC gene. The earlier the diagnosis, the better the prognosis. Therefore, convenient and inexpensive detection method is needed.
View Article and Find Full Text PDFJ Neurol
January 2025
Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Background: Neurologic symptoms seen in patients receiving immune checkpoint inhibitors (ICI) may not be entirely caused by immunotoxicity. We aim to highlight these confounding conditions through clinical cases to encourage early recognition and management.
Methods: We describe a series of seven cases from our institution that were treated with ICI and presented with Neurologic symptoms and were diagnosed with superimposed conditions beyond immunotoxicity.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!